从人类胚胎或诱导多能干细胞中获得功能性β细胞的逐步方法
Clara Farhat1,2, Viktoria Xega1,2, Jun-Li Liu1,2
1MeDiC Program, The Research Institute of McGill University Health Centre, Montreal, Canada.
Medical review (2021)
|February 20, 2025
概括
从干细胞生成功能性β细胞是糖尿病治疗的关键. 研究人员正在改进使用人类胚胎干细胞 (hESC) 和诱导多能干细胞 (iPSC) 的协议,以改善葡萄糖刺激的胰岛素分泌.
科学领域:
- 干细胞生物学 干细胞生物学
- 内分泌学 在内分泌学.
- 再生医学是一种再生医学.
背景情况:
- 多能干细胞 (PSC) 为β细胞替代疗法提供了一个有前途的来源.
- 目前的分化协议在实现强大的葡萄糖刺激胰岛素分泌 (GSIS) 方面面临挑战.
- 了解非线性差异化途径和关键监管因素至关重要.
研究的目的:
- 审查贝塔细胞与PSC差异化方面的进展.
- 突出改善功能性胰岛素生产的策略.
- 讨论特定标记物和细胞组织在β细胞发育中的作用.
主要方法:
- 使用人类胚胎干细胞 (hESC) 和诱导多能干细胞 (iPSC).
- 采用针对胰腺血统承诺的主调节基因的协议.
- 调查关键因素和成熟β细胞标记物如MAFA的共同表达的作用.
主要成果:
- 在将PSC指向胰腺β细胞方面取得了进展.
- 增强的协议改善了功能性胰岛素产生细胞的产生.
- MAFA的表达对于维护β细胞的身份和功能至关重要.
- 胰腺小岛类集群显示出增强生理反应的潜力.
结论:
- 贝塔细胞与PSC的分化是复杂的,但进展迅速.
- 优化协议和对调节机制的理解对于治疗应用至关重要.
- 这些进步具有巨大的潜力,可以通过再生医学彻底改变糖尿病治疗.
相关概念视频
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Induced Pluripotent Stem Cells
21.8K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
21.8K


